Impact of Clinician Feedback Reports on Antibiotic Use in Children Hospitalized With Community-acquired Pneumonia.

IF 8.2 1区 医学 Q1 IMMUNOLOGY
Kathleen Chiotos, Lauren Dutcher, Robert W Grundmeier, Didien Meyahnwi, Ebbing Lautenbach, Melinda M Neuhauser, Lauri A Hicks, Keith W Hamilton, Yun Li, Julia E Szymczak, Brandi M Muller, Morgan Congdon, Emily Kane, Jessica Hart, Levon Utidjian, Leigh Cressman, Anne Jaskowiak-Barr, Jeffrey S Gerber
{"title":"Impact of Clinician Feedback Reports on Antibiotic Use in Children Hospitalized With Community-acquired Pneumonia.","authors":"Kathleen Chiotos, Lauren Dutcher, Robert W Grundmeier, Didien Meyahnwi, Ebbing Lautenbach, Melinda M Neuhauser, Lauri A Hicks, Keith W Hamilton, Yun Li, Julia E Szymczak, Brandi M Muller, Morgan Congdon, Emily Kane, Jessica Hart, Levon Utidjian, Leigh Cressman, Anne Jaskowiak-Barr, Jeffrey S Gerber","doi":"10.1093/cid/ciae593","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Feedback reports summarizing clinician performance are effective tools for improving antibiotic use in the ambulatory setting, but the effectiveness of feedback reports in the hospital setting is unknown.</p><p><strong>Methods: </strong>Quasi-experimental study conducted between December 2021 and November 2023 within a pediatric health system measuring the impact of clinician feedback reports delivered by email and reviewed in a monthly meeting on appropriate antibiotic use in children hospitalized with community-acquired pneumonia (CAP). We used an interrupted time series analysis (ITSA) to estimate the immediate change and change over time in the proportion of CAP encounters adherent to validated metrics of antibiotic choice and duration, then used Poisson regression to estimate intervention effect as a risk ratio (RR).</p><p><strong>Results: </strong>Preintervention, 213 of 413 (52%) encounters received the appropriate antibiotic choice and duration, which increased to 308 of 387 (80%) postintervention. The ITSA demonstrated an immediate 18% increase in the proportion of CAP encounters receiving both the appropriate antibiotic choice and duration (95% confidence interval [CI]: 3-33%), with no further change over time (-0.3% per month, 95% CI: -2%-2%). In the Poisson model adjusted for age, sex, race, season, site, and intensive care unit admission, the intervention was associated with a 32% increase in the rate of appropriate antibiotic choice and duration (RR 1.32, 95% CI: 1.12-1.56, P < .01). No difference in length of stay or revisits were detected postintervention.</p><p><strong>Conclusions: </strong>The intervention was associated with an increase in clinician adherence to antibiotic choice and duration recommendations for children hospitalized with CAP.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"263-270"},"PeriodicalIF":8.2000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciae593","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Feedback reports summarizing clinician performance are effective tools for improving antibiotic use in the ambulatory setting, but the effectiveness of feedback reports in the hospital setting is unknown.

Methods: Quasi-experimental study conducted between December 2021 and November 2023 within a pediatric health system measuring the impact of clinician feedback reports delivered by email and reviewed in a monthly meeting on appropriate antibiotic use in children hospitalized with community-acquired pneumonia (CAP). We used an interrupted time series analysis (ITSA) to estimate the immediate change and change over time in the proportion of CAP encounters adherent to validated metrics of antibiotic choice and duration, then used Poisson regression to estimate intervention effect as a risk ratio (RR).

Results: Preintervention, 213 of 413 (52%) encounters received the appropriate antibiotic choice and duration, which increased to 308 of 387 (80%) postintervention. The ITSA demonstrated an immediate 18% increase in the proportion of CAP encounters receiving both the appropriate antibiotic choice and duration (95% confidence interval [CI]: 3-33%), with no further change over time (-0.3% per month, 95% CI: -2%-2%). In the Poisson model adjusted for age, sex, race, season, site, and intensive care unit admission, the intervention was associated with a 32% increase in the rate of appropriate antibiotic choice and duration (RR 1.32, 95% CI: 1.12-1.56, P < .01). No difference in length of stay or revisits were detected postintervention.

Conclusions: The intervention was associated with an increase in clinician adherence to antibiotic choice and duration recommendations for children hospitalized with CAP.

临床医生反馈报告对社区获得性肺炎住院儿童抗生素使用的影响
背景:总结临床医生表现的反馈报告是改善门诊环境中抗生素使用的有效工具,但反馈报告在医院环境中的有效性尚不清楚。方法:于2021年12月至2023年11月在儿科卫生系统内进行准实验研究,测量临床医生通过电子邮件反馈报告的影响,并在每月会议上审查社区获得性肺炎(CAP)住院儿童适当使用抗生素的情况。我们使用中断时间序列分析(ITSA)来估计符合抗生素选择和持续时间的有效指标的CAP接触比例的即时变化和随时间的变化,然后使用泊松回归来估计干预效果作为比率比(RR)。结果:干预前,413例患者中有213例(52%)接受了适当的抗生素选择和治疗时间,干预后387例患者中有308例(80%)接受了适当的抗生素选择和治疗时间。ITSA显示,接受适当抗生素选择和持续时间的CAP就诊比例立即增加了18%(95%置信区间,3-33%),随着时间的推移没有进一步变化(每月-0.3%,95%置信区间-2-2%)。在调整了年龄、性别、种族、季节、地点和重症监护病房入住的泊松模型中,干预与适当抗生素选择率和持续时间增加32%相关(RR 1.32, 95%可信区间1.12-1.56,P)。结论:干预与临床医生对CAP住院儿童抗生素选择和持续时间推荐的依从性增加相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Infectious Diseases
Clinical Infectious Diseases 医学-传染病学
CiteScore
25.00
自引率
2.50%
发文量
900
审稿时长
3 months
期刊介绍: Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信